SAP:XETRSAP SE Analysis
Data as of 2026-03-09 - not real-time
$200.68
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
SAP shares are trading at $200.68, just below the 20‑day SMA of $201.55 and well under the 50‑day SMA of $218.67, indicating short‑term pressure. The RSI sits at 44.6, suggesting neutral momentum, while the MACD histogram turned positive (+1.36) signaling a potential near‑term bounce. Volatility is elevated at 60 % over the past 30 days, and the beta of 0.82 points to moderate market sensitivity. Support at $187.94 and resistance near $212.98 frame the current trading range.
Fundamentally, SAP delivers a robust 73.8 % gross margin and a healthy 29 % operating margin, with revenue growing 3.3 % YoY. The forward PE of 20× is well below the industry average of 36.7×, and the dividend yield of 1.47 % is backed by a 38 % payout ratio and strong cash generation (≈$9.5 B cash vs $7.5 B debt). The recent AI‑first partnership with KPMG adds a strategic growth catalyst. Overall, the stock appears fairly priced relative to peers but modestly overvalued against its own DCF estimate, leaving upside potential toward analyst targets around $300.
Fundamentally, SAP delivers a robust 73.8 % gross margin and a healthy 29 % operating margin, with revenue growing 3.3 % YoY. The forward PE of 20× is well below the industry average of 36.7×, and the dividend yield of 1.47 % is backed by a 38 % payout ratio and strong cash generation (≈$9.5 B cash vs $7.5 B debt). The recent AI‑first partnership with KPMG adds a strategic growth catalyst. Overall, the stock appears fairly priced relative to peers but modestly overvalued against its own DCF estimate, leaving upside potential toward analyst targets around $300.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price hovering just below the 20‑day SMA suggests limited upside
- Positive MACD histogram indicates a possible short‑term bounce
- High 30‑day volatility and bearish trend direction increase uncertainty
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Forward PE of 20× is well under the industry average of 36.7×
- Strong operating margins and cash flow support earnings growth
- Analyst target median price of $304 implies >50% upside
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Strategic AI‑first alliance with KPMG expands future growth opportunities
- Sustainable dividend payout with low payout ratio and solid balance sheet
- Stable revenue growth and high gross margin underpin long‑term profitability
Key Metrics & Analysis
Financial Health
Revenue Growth3.30%
Profit Margin19.46%
P/E Ratio28.3
ROE16.12%
ROA9.01%
Debt/Equity16.59
P/B Ratio4.5
Op. Cash Flow$9.2B
Free Cash Flow$8.5B
Industry P/E36.7
Technical Analysis
TrendBearish
RSI44.6
Support$187.94
Resistance$212.98
MA 20$201.55
MA 50$218.67
MA 200$260.48
MACDBullish
VolumeIncreasing
Fear & Greed Index100
Valuation
Fair Value$118.06
Target Price$299.50
Upside/Downside49.25%
GradeFair
TypeBlend
Dividend Yield1.47%
Risk Assessment
Beta0.82
Volatility60.07%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.